DrugInteractions:CYP2D6substrateDosage andAdministration:Weekly dosingDosageForm andStrengths:Nasal sprayDrugInteractions:InteractionwithamiodaroneDosageForm andStrengths:VaginalproductDrugInteractions:CYP3A4inhibitorDosage andAdministration:Once-dailydosingContraindications,Warnings, andPrecautions: Riskof bleedingContraindications,Warnings, andPrecautions: Riskof hepatotoxicityIndicationsandUsage:PainPatientCounselingInformation:Advises avoidingalcoholconsumptionUse in SpecificPopulations:Hepaticimpairmentuse describedDosageForm andStrengths:InjectablemedicationIndications andUsage:Asthma/COPDUse inSpecificPopulations:Geriatric usedescribedContraindications,Warnings, andPrecautions: Riskof QT prolongationDrug AbuseandDependence:Risk forDependenceDosageForm andStrengths:TransdermalpatchDrugInteractions:Interactionwith warfarinDosage andAdministration:Dose adjustmentrequired forhepaticimpairmentDrug AbuseandDependence:Risk for Abuse,MisuseUse in SpecificPopulations:NotrecommendedduringpregnancyPatientCounselingInformation:Containsmissed doseinstructionsDrugInteractions:CYP2D6inhibitorIndicationsandUsage:ADHDIndications andUsage: Hasmultiple FDA-approvedindications foruseDosageForm andStrengths:OphthalmicproductDrugInteractions:CYP3A4substrateAdverse Reactions:May causedrowsiness/sedationHowSupplied/Storageand Handling:RefrigerationrequiredPatientCounselingInformation:Advises use ofcontraceptionUse in SpecificPopulations:Notrecommendedduring lactationAdverseReactions:May causenauseaDosage Formand Strengths:Extended-releaseformulationHowSupplied/Storageand Handling:Store at roomtemperatureContraindications,Warnings, andPrecautions: Riskof nephrotoxicityContraindications,Warnings, andPrecautions: Riskof severe rashContraindications,Warnings, andPrecautions: Riskof C. difficileinfectionDosage andAdministration:Twice-dailydosingDosageForm andStrengths:InhaledmedicationIndicationsand Usage:Anti-infectiveContraindications,Warnings, andPrecautions: Riskof respiratorydepressionContraindications,Warnings, andPrecautions: Riskof serotoninsyndromeAdverseReactions:May causeheadacheAdverseReactions:10+ AdverseReactionslistedContraindications,Warnings, andPrecautions: Riskof hypoglycemiaDosageForm andStrengths:Oral tabletAdverseReactions:May causeweight gainIndicationsand Usage:DepressionDrug AbuseandDependence:ControlledSubstance(Schedule II-V)HowSupplied/Storageand Handling:Protect from lightDosageForm andStrengths:Oral capsuleUse inSpecificPopulations:Pediatric usedescribedAdverseReactions:May causeweight lossDrugInteractions:CYP3A4inducerDosage andAdministration:Doseadjustmentrequired forrenal impairmentDosageForm andStrengths:RectalproductUse in SpecificPopulations:Renalimpairmentuse describedPatientCounselingInformation:Advises limitingsun exposureDosageForm andStrengths:Oral solutionIndicationsandUsage:DiabetesUse in SpecificPopulations: Hasreproductivetoxicity/teratogenicitywarningContraindications,Warnings, andPrecautions: BlackBox WarningDrugInteractions:CYP2C9inhibitorDrugInteractions:CYP2C9substrateIndicationsand Usage:HypertensionDosageForm andStrengths:TopicalproductDrugInteractions:InteractionwithgrapefruitPatient CounselingInformation:Advises againstdriving oroperating heavymachineryDrugInteractions:CYP2D6substrateDosage andAdministration:Weekly dosingDosageForm andStrengths:Nasal sprayDrugInteractions:InteractionwithamiodaroneDosageForm andStrengths:VaginalproductDrugInteractions:CYP3A4inhibitorDosage andAdministration:Once-dailydosingContraindications,Warnings, andPrecautions: Riskof bleedingContraindications,Warnings, andPrecautions: Riskof hepatotoxicityIndicationsandUsage:PainPatientCounselingInformation:Advises avoidingalcoholconsumptionUse in SpecificPopulations:Hepaticimpairmentuse describedDosageForm andStrengths:InjectablemedicationIndications andUsage:Asthma/COPDUse inSpecificPopulations:Geriatric usedescribedContraindications,Warnings, andPrecautions: Riskof QT prolongationDrug AbuseandDependence:Risk forDependenceDosageForm andStrengths:TransdermalpatchDrugInteractions:Interactionwith warfarinDosage andAdministration:Dose adjustmentrequired forhepaticimpairmentDrug AbuseandDependence:Risk for Abuse,MisuseUse in SpecificPopulations:NotrecommendedduringpregnancyPatientCounselingInformation:Containsmissed doseinstructionsDrugInteractions:CYP2D6inhibitorIndicationsandUsage:ADHDIndications andUsage: Hasmultiple FDA-approvedindications foruseDosageForm andStrengths:OphthalmicproductDrugInteractions:CYP3A4substrateAdverse Reactions:May causedrowsiness/sedationHowSupplied/Storageand Handling:RefrigerationrequiredPatientCounselingInformation:Advises use ofcontraceptionUse in SpecificPopulations:Notrecommendedduring lactationAdverseReactions:May causenauseaDosage Formand Strengths:Extended-releaseformulationHowSupplied/Storageand Handling:Store at roomtemperatureContraindications,Warnings, andPrecautions: Riskof nephrotoxicityContraindications,Warnings, andPrecautions: Riskof severe rashContraindications,Warnings, andPrecautions: Riskof C. difficileinfectionDosage andAdministration:Twice-dailydosingDosageForm andStrengths:InhaledmedicationIndicationsand Usage:Anti-infectiveContraindications,Warnings, andPrecautions: Riskof respiratorydepressionContraindications,Warnings, andPrecautions: Riskof serotoninsyndromeAdverseReactions:May causeheadacheAdverseReactions:10+ AdverseReactionslistedContraindications,Warnings, andPrecautions: Riskof hypoglycemiaDosageForm andStrengths:Oral tabletAdverseReactions:May causeweight gainIndicationsand Usage:DepressionDrug AbuseandDependence:ControlledSubstance(Schedule II-V)HowSupplied/Storageand Handling:Protect from lightDosageForm andStrengths:Oral capsuleUse inSpecificPopulations:Pediatric usedescribedAdverseReactions:May causeweight lossDrugInteractions:CYP3A4inducerDosage andAdministration:Doseadjustmentrequired forrenal impairmentDosageForm andStrengths:RectalproductUse in SpecificPopulations:Renalimpairmentuse describedPatientCounselingInformation:Advises limitingsun exposureDosageForm andStrengths:Oral solutionIndicationsandUsage:DiabetesUse in SpecificPopulations: Hasreproductivetoxicity/teratogenicitywarningContraindications,Warnings, andPrecautions: BlackBox WarningDrugInteractions:CYP2C9inhibitorDrugInteractions:CYP2C9substrateIndicationsand Usage:HypertensionDosageForm andStrengths:TopicalproductDrugInteractions:InteractionwithgrapefruitPatient CounselingInformation:Advises againstdriving oroperating heavymachinery

BINGO Rx - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
  1. Drug Interactions: CYP2D6 substrate
  2. Dosage and Administration: Weekly dosing
  3. Dosage Form and Strengths: Nasal spray
  4. Drug Interactions: Interaction with amiodarone
  5. Dosage Form and Strengths: Vaginal product
  6. Drug Interactions: CYP3A4 inhibitor
  7. Dosage and Administration: Once-daily dosing
  8. Contraindications, Warnings, and Precautions: Risk of bleeding
  9. Contraindications, Warnings, and Precautions: Risk of hepatotoxicity
  10. Indications and Usage: Pain
  11. Patient Counseling Information: Advises avoiding alcohol consumption
  12. Use in Specific Populations: Hepatic impairment use described
  13. Dosage Form and Strengths: Injectable medication
  14. Indications and Usage: Asthma/COPD
  15. Use in Specific Populations: Geriatric use described
  16. Contraindications, Warnings, and Precautions: Risk of QT prolongation
  17. Drug Abuse and Dependence: Risk for Dependence
  18. Dosage Form and Strengths: Transdermal patch
  19. Drug Interactions: Interaction with warfarin
  20. Dosage and Administration: Dose adjustment required for hepatic impairment
  21. Drug Abuse and Dependence: Risk for Abuse, Misuse
  22. Use in Specific Populations: Not recommended during pregnancy
  23. Patient Counseling Information: Contains missed dose instructions
  24. Drug Interactions: CYP2D6 inhibitor
  25. Indications and Usage: ADHD
  26. Indications and Usage: Has multiple FDA-approved indications for use
  27. Dosage Form and Strengths: Ophthalmic product
  28. Drug Interactions: CYP3A4 substrate
  29. Adverse Reactions: May cause drowsiness/sedation
  30. How Supplied/Storage and Handling: Refrigeration required
  31. Patient Counseling Information: Advises use of contraception
  32. Use in Specific Populations: Not recommended during lactation
  33. Adverse Reactions: May cause nausea
  34. Dosage Form and Strengths: Extended-release formulation
  35. How Supplied/Storage and Handling: Store at room temperature
  36. Contraindications, Warnings, and Precautions: Risk of nephrotoxicity
  37. Contraindications, Warnings, and Precautions: Risk of severe rash
  38. Contraindications, Warnings, and Precautions: Risk of C. difficile infection
  39. Dosage and Administration: Twice-daily dosing
  40. Dosage Form and Strengths: Inhaled medication
  41. Indications and Usage: Anti-infective
  42. Contraindications, Warnings, and Precautions: Risk of respiratory depression
  43. Contraindications, Warnings, and Precautions: Risk of serotonin syndrome
  44. Adverse Reactions: May cause headache
  45. Adverse Reactions: 10+ Adverse Reactions listed
  46. Contraindications, Warnings, and Precautions: Risk of hypoglycemia
  47. Dosage Form and Strengths: Oral tablet
  48. Adverse Reactions: May cause weight gain
  49. Indications and Usage: Depression
  50. Drug Abuse and Dependence: Controlled Substance (Schedule II-V)
  51. How Supplied/Storage and Handling: Protect from light
  52. Dosage Form and Strengths: Oral capsule
  53. Use in Specific Populations: Pediatric use described
  54. Adverse Reactions: May cause weight loss
  55. Drug Interactions: CYP3A4 inducer
  56. Dosage and Administration: Dose adjustment required for renal impairment
  57. Dosage Form and Strengths: Rectal product
  58. Use in Specific Populations: Renal impairment use described
  59. Patient Counseling Information: Advises limiting sun exposure
  60. Dosage Form and Strengths: Oral solution
  61. Indications and Usage: Diabetes
  62. Use in Specific Populations: Has reproductive toxicity/teratogenicity warning
  63. Contraindications, Warnings, and Precautions: Black Box Warning
  64. Drug Interactions: CYP2C9 inhibitor
  65. Drug Interactions: CYP2C9 substrate
  66. Indications and Usage: Hypertension
  67. Dosage Form and Strengths: Topical product
  68. Drug Interactions: Interaction with grapefruit
  69. Patient Counseling Information: Advises against driving or operating heavy machinery